Current Problems in Cardiology
Volume 31, Issue 7 , Pages 445-486 , July 2006

Pathophysiology, Diagnosis, and Management of Dyslipidemia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Disclosures: Gerald T. Gau, MD, Principle investigator in the COURAGE Trial and a member of the Executive Committee, was supported by the Department of Veterans Affairs Cooperative Studies Program, in collaboration with the Canadian government CIHR. R. Scott Wright, MD, received research support from Bayer, Bristol-Myers Squibb, Merck, and Johnson & Johnson and worked as a consultant for Pfizer and Merck-Schering Plough.

PII: S0146-2806(06)00036-3

doi: 10.1016/j.cpcardiol.2006.03.001

Current Problems in Cardiology
Volume 31, Issue 7 , Pages 445-486 , July 2006

Article Tools

* Image Usage & Resolution